Pulmonary tumor thrombotic microangiopathy (PTTM) is a fatal disease process in which
pulmonary hypertension (PH) develops in the setting of malignancy. The purpose of this …

Objective To determine common etiologies, presentations, management strategies and
outcomes in patients with tumor embolism causing acute arterial occlusion. Study design …

The incidence of pulmonary embolism (PE) is estimated to be 112 cases per 100,000 US
population. Since 1998, the incidence of PE has nearly doubled, but mortality from PE has …

Pulmonary tumor embolisms (PTEs) are primarily caused by adenocarcinoma. However,
only a few cases of oropharyngeal carcinoma have been reported. We herein report a 47 …

Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare rapidly progressive fatal
disease that is difficult to diagnosis antemortem. Activation of the coagulation cascade and …

Background Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare malignancy-
related respiratory complication, demonstrating rapid progression of pulmonary …

Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare cancer-related complication
characterized by intimal proliferation in the pulmonary small arteries with or without tumor …

Pulmonary tumor thrombotic microangiopathy (PTTM) is a fatal disease process in which
pulmonary hypertension (PH) develops in the setting of malignancy. The purpose of this …